跳至主要内容
临床试验/NCT00170378
NCT00170378已完成4 期

The Use of Low Molecular Weight Heparin in Traumatic Brain Injury

Hennepin Healthcare Research Institute2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2002年12月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
300
试验地点
2
主要终点
Safety: Assess if early administration of LMWH exacerbates intracranial hemorrhage.

研究概览

简要总结

To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury.

详细描述

Venous thromboembolic (VTE) prophylaxis in trauma patients is a critical clinical problem. Patients with traumatic brain injury usually have effective VTE prophylaxis withheld secondary to concerns of exacerbating intracranial hemorrhage. This study examines the safety and efficacy of early administration (within 24 hrs of admission) of low molecular weight heparin to this patient population with very high VTE risk.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Blunt traumatic brain injury (Marshall II-V)
  • Stable 6 hr. head CT
  • Stable hemoglobin

排除标准

  • Premorbid coagulopathy
  • Pregnancy
  • < 18 y.o.
  • Need for therapeutic anticoagulation
  • Heparin allergy

结局指标

主要结局

Safety: Assess if early administration of LMWH exacerbates intracranial hemorrhage.

次要结局

  • Efficacy: Demonstrate effectiveness of dosing regimen in preventing VTE.

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验